Download medicine data

You can download tables with detailed data on medicines from this page. This includes information on marketing authorisations of centrally authorised medicines and post-authorisation procedures.

You can download data related to medicines published on EMA's website in table format. The website automatically updates these data tables overnight.

To stay up-to-date with new and updated information on this website, see:

• What's new

Medicines

Find the following types of information on medicines in the table below:

• Approved medicines
• Withdrawn applications for new marketing authorisations
• Status of opinions

Download medicines data table

All relevant information and documents on medicines authorised at a European Union (EU) level are available on medicine pages. This includes:

• Full scientific assessment reports
• Public-friendly overviews in question-and-answer format
• Package leaflets

These pages also contain information on medicines for which the European Commission has refused a marketing authorisation, or has suspended or withdrawn the marketing authorisation after approval.

More up-to-date information on veterinary medicinal products is available on the Veterinary Medicines Information website.

For more information, see:

• Medicines for human use under evaluation

Post-authorisation procedures for medicines

Find information on opinions on post-authorisation procedures and withdrawn applications in the table below.

Download post-authorisation procedures for medicines data table

During the post-authorisation stage of a medicine life-cycle, marketing authorisation holders can submit an application to change the terms of marketing authorisation. This is known as a variation.

At any stage of the assessment process, applicants can withdraw the application to EMA.

Information on approved post-authorisation procedures is available on medicine pages.

For more information, see:

• Variations including extensions of marketing authorisations

Referrals

Find information on all ongoing and completed referrals in the table below.

Download referrals data table

For more information, see:

• Referral procedures: human medicines
• Referral procedures: veterinary medicines

Paediatric investigation plans

Find information on decisions related to paediatric investigation plans following evaluation from the Paediatric Committee (PDCO) in the table below.

Download paediatric investigation plans data table

For more information, see:

• Paediatric medicines: Overview
• Paediatric investigation plans

Orphan designations

Find information on the status of orphan designations following assessment from the Committee for Orphan Medicinal Products (COMP) in the table below.

Download orphan designations data table

For more information, see:

• Orphan designation: Overview

Periodic safety update report single assessments (PSUSAs)

Find information on the regulatory outcomes of periodic safety update report single assessments (PSUSAs) in the table below.

Download period safety update report single assessments data table

Marketing authorisation holders periodically submit PSURs following a medicine's authorisation. EMA and national competent authorities carry out a single joint assessment of all medicines containing the same active substance or combination of active substances to determine if there is a need to update marketing authorisations.

For more information, see:

• Periodic safety update reports (PSURs)

Direct healthcare professional communications (DHPCs)

Find information on direct healthcare professional communication (DHPCs) for human and veterinary medicines in the table below. These contain important new safety information about a medicine, including recommended actions that healthcare professionals should take.

Download direct healthcare professional communications data table

For more information, see:

• Direct healthcare professional communications (DHPCs)
• Direct animal healthcare professional communications (DaHPCs)

Medicine supply shortages

Find information on ongoing and resolved medicine supply shortages assessed by EMA in the table below. The table includes links to individual shortage notices that contain valuable information for healthcare professionals and patients, along with details on the availability of alternatives.

Download medicine supply shortages data table

For each shortage, additional information about the situation in a specific country may be available from the national competent authority.

For more information, see:

• Medicine shortages and availability issues
• Availability of medicines before and during crises

Herbal medicines

Find information on the status and outcomes of assessments from EMA's Committee on Herbal Medicinal Products (HMPC) in the table below.

Download herbal medicines data table

For more information, see:

• Herbal medicinal products

Medicines for use outside EU

Find information on the status of EMA's scientific opinions on high priority medicines for use outside of the EU in the table below.

Download medicines for use outside EU data table

For more information, see:

• Medicines for use outside the European Union

Maximum residue limits (MRLs)

Find information on maximum residue limits (MRLs) in the table below.

Download maximum residue limits (MRLs) data table

For more information, see:

• Maximum residue limits (MRLs)

JSON data format files

EMA’s entire website is available in JSON format for automated use. For medicines and related procedures, the data provided is identical to that provided in the tables on this page.

Check our JSON data files

Page update history

An update log is available to show the date and summary of changes to this webpage. It does not include updates to linked documents or minor edits like typos or broken link fixes.

The tracking of updates begins in April 2026.

See update history

10 April 2026

Maximum residue limits (MRLs) section added